US EditionNeurocrine Biosciences to Present at Upcoming Investor Conferences in March
Neurocrine Biosciences management will engage investors at the TD Cowen Health Care Conference to discuss company plans and future performance forecasts.
- On Feb. 24, 2026, Neurocrine announced management will participate at upcoming investor conferences, including the TD Cowen 46th Annual Health Care Conference.
- Company representatives said presentations may include forward‑looking statements about plans and financial guidance, identifiable by words like 'expect', 'plan' and 'guidance' as defined in the company's notice.
- Neurocrine named the TD Cowen 46th Annual Health Care Conference and said management team members will present.
- The company cautioned that forward‑looking statements are subject to substantial risks and uncertainties, and it assumes no obligation to update them after they are made.
- Public dissemination via ACCESS Newswire and PRNewswire on Feb. 24, 2026, ensured broad notice to investor audiences, the company said.
38 Articles
38 Articles
Brunswicktimes Gazette
Novavax to Participate in Upcoming Investor Conferences
GAITHERSBURG, Md., Feb. 26, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), today announced that it will participate in the following upcoming investor conferences:
Armanino Foods to Participate in Upcoming Investor Conferences
PLEASANTON, CA / ACCESS Newswire / February 25, 2026 / Armanino Foods of Distinction, Inc. (OTCQX:AMNF), a leading provider of pesto and specialty frozen foods for North American foodservice, retail, and industrial customers, today announced that management will participate in…
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March
NAARDEN, the Netherlands and MIAMI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with…
The Record
Teva to Present at the Upcoming Investor Conferences in March
PARSIPPANY, N.J. and TEL AVIV, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will participate in the upcoming investor conferences in March as follows:
Coverage Details
Bias Distribution
- 50% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium